🇺🇸 FDA
Pipeline program

Erythromycin 4% topical gel formulation

CHDR1732

Approved small_molecule active

Quick answer

Erythromycin 4% topical gel formulation for Acne Vulgaris is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Acne Vulgaris
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials